Researchers discovered that a significant proportion of rheumatoid arthritis (RA) patients are not receiving the latest recommended treatments.
Researchers from Wake Forest Baptist Medical Center concluded that medications that treat attention-deficit/hyperactivity disorder (ADHD) may not be harmful when used in the long term.
A pair of high-ranking healthcare advertising professionals advocate for a strategy that involves combining multiple mediums.
Medicare patients had difficulty taking the appropriate amount of their medications after surviving a heart attack.
The AIDS Healthcare Foundation (AHF) is asking Gilead Sciences to offer the same lower prices for Stribild, negotiated with AIDS Drug Assistance Programs (ADAPs), to patients who are covered by Medicare, Medicaid and other types of insurance.
Pfizer launched a new online community to gather information about people's attitudes and unmet needs in the context of aging. The website connects people to an ongoing conversation while informing healthcare marketing, research and development for solutions in this community.
Researchers from the University of Colorado Cancer Center discovered that a protein needed for the progression of bladder cancer may become less abundant in response to anti-androgen therapy.
Individuals who live with chronic obstructive pulmonary disease (COPD) may be able to avert exacerbations of their condition with the help of a preventive regimen of azithromycin, according to new research.
A new study reveals that the anti-estrogen medication tamoxifen may help alleviate breast pain and enlargement in prostate cancer patients who undergo androgen-suppression therapy.
An analysis published by the journal ACS Chemical Neuroscience highlights the latest trends in pharmaceutical sales, particularly among drugs that are directed at the central nervous system (CNS).